Cyclacel (NASDAQ:CYCCP) declared a quarterly dividend on Friday, March 16th, Wall Street Journal reports. Investors of record on Wednesday, April 11th will be paid a dividend of 0.15 per share on Tuesday, May 1st. This represents a $0.60 dividend on an annualized basis and a yield of 9.16%. The ex-dividend date of this dividend is Tuesday, April 10th.
NASDAQ CYCCP traded up $0.26 during mid-day trading on Friday, reaching $6.55. 1,300 shares of the stock were exchanged, compared to its average volume of 700. Cyclacel has a one year low of $5.11 and a one year high of $8.75.
COPYRIGHT VIOLATION NOTICE: “Cyclacel Declares Quarterly Dividend of $0.15 (CYCCP)” was published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this story on another site, it was stolen and republished in violation of United States and international copyright and trademark legislation. The legal version of this story can be viewed at https://www.dispatchtribunal.com/2018/04/08/cyclacel-pharmaceuticals-inc-cyccp-declares-0-15-quarterly-dividend.html.
Cyclacel Pharmaceuticals, Inc, a biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's oncology development programs include sapacitabine, a novel orally-available nucleoside analog that is in Phase III clinical trial for the front-line treatment of acute myeloid leukemia; and Phase II clinical trial for the treatment of myelodysplastic syndromes.
Receive News & Ratings for Cyclacel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cyclacel and related companies with MarketBeat.com's FREE daily email newsletter.